BCWORLD PHARM. Co. Ltd (200780) — Cash Flow-to-Debt Ratio
BCWORLD PHARM. Co. Ltd (200780) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of ₩1.43 Billion could theoretically repay 0% of its total liabilities (₩101.30 Billion) in one year. Explore 200780 long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
BCWORLD PHARM. Co. Ltd Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for BCWORLD PHARM. Co. Ltd across 10 annual periods. Also explore total assets of BCWORLD PHARM. Co. Ltd for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for BCWORLD PHARM. Co. Ltd (2015–2024)
Year-by-year debt coverage analysis for BCWORLD PHARM. Co. Ltd. For market capitalisation and broader financial context, see BCWORLD PHARM. Co. Ltd market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.04x | ₩4.04 Billion | ₩99.65 Billion | ▼ -62.0% |
| 2023 | 0.11x | ₩10.94 Billion | ₩102.47 Billion | ▲ +60.5% |
| 2022 | 0.07x | ₩6.88 Billion | ₩103.50 Billion | ▲ +1150.4% |
| 2021 | -0.01x | ₩-619.83 Million | ₩97.90 Billion | ▲ +89.5% |
| 2020 | -0.06x | ₩-5.50 Billion | ₩91.27 Billion | ▼ -137.6% |
| 2019 | 0.16x | ₩12.11 Billion | ₩75.53 Billion | ▲ +115.1% |
| 2018 | 0.07x | ₩5.34 Billion | ₩71.65 Billion | ▼ -65.0% |
| 2017 | 0.21x | ₩7.90 Billion | ₩37.11 Billion | ▲ +1869.4% |
| 2016 | 0.01x | ₩243.66 Million | ₩22.54 Billion | ▼ -98.5% |
| 2015 | 0.73x | ₩8.78 Billion | ₩11.96 Billion | — |